Fitusiran — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-11-05 in 2mo
ESTIMATED |
READOUT
Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A o
Phase 3 · Hemophilia |
Genzyme, a Sanofi Company | Fitusiran |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|